Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
P & T : a Peer-Reviewed Journal for Formulary Management|September 6, 2019
Antibiotic Breakpoints: How Redefining Susceptibility Preserves Efficacy and Improves Patient CareMark Redell, Glenn Tillotson
The Journal of Antimicrobial Chemotherapy|January 20, 2004
Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzaeIan Morrissey, Glenn Tillotson
International Journal of Antimicrobial Agents|February 16, 2008
Role of gemifloxacin in the management of community-acquired lower respiratory tract infectionsJoseph M Blondeau, Glenn Tillotson
BMC Infectious Diseases|March 7, 2023
The burden of CDI in the United States: a multifactorial challengePaul Feuerstadt, Nicolette Theriault, Glenn Tillotson
Expert Review of Anti-Infective Therapy|October 7, 2009
Topical antibiotic treatment for uncomplicated skin and skin structure infections: review of the literatureRonald Pangilinan, Alan Tice, Glenn Tillotson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2019
Analysis of Pooled Phase 3 Safety Data for Delafloxacin in Acute Bacterial Skin and Skin Structure InfectionsMatteo Bassetti, David Hooper, Glenn Tillotson
Infection and Drug Resistance|February 20, 2024
Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the DetailsLea Monday, Glenn Tillotson, Teena Chopra
Pageof 6